National Research Corp logo

National Research Corp - Class A

STU:NR1A (USA)   Class A
€ 36.00 (-1.1%) Mar 27
31.59
P/B:
19.54
Market Cap:
€ 869.67M ($ 938.26M)
Enterprise V:
€ 897.40M ($ 968.17M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for National Research Corp ( ) from 2017 to Mar 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. National Research stock (STU:NR1A) PE ratio as of Mar 28 2024 is 31.59. More Details

National Research Corp (STU:NR1A) PE Ratio (TTM) Chart

To

National Research Corp (STU:NR1A) PE Ratio (TTM) Historical Data

Total 1260
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
National Research PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-03-28 31.0 2024-01-25 31.2
2024-03-27 31.0 2024-01-24 31.0
2024-03-26 31.4 2024-01-23 31.2
2024-03-25 31.2 2024-01-22 31.0
2024-03-22 31.4 2024-01-19 30.5
2024-03-21 31.0 2024-01-18 30.9
2024-03-20 31.2 2024-01-17 31.0
2024-03-19 31.2 2024-01-16 31.0
2024-03-18 31.2 2024-01-12 30.3
2024-03-15 30.7 2024-01-11 29.8
2024-03-14 30.7 2024-01-10 30.2
2024-03-13 30.9 2024-01-09 29.7
2024-03-12 31.2 2024-01-08 29.5
2024-03-11 31.0 2024-01-05 30.3
2024-03-08 31.4 2024-01-04 31.4
2024-03-07 31.4 2024-01-03 32.1
2024-03-06 31.4 2024-01-02 31.7
2024-03-05 31.0 2023-12-29 29.8
2024-03-04 31.4 2023-12-28 30.0
2024-03-01 31.4 2023-12-27 32.3
2024-02-29 31.7 2023-12-22 32.3
2024-02-28 31.7 2023-12-21 32.4
2024-02-27 31.4 2023-12-20 32.4
2024-02-26 31.0 2023-12-19 32.8
2024-02-23 31.2 2023-12-18 33.2
2024-02-22 30.7 2023-12-15 32.6
2024-02-21 30.3 2023-12-14 33.9
2024-02-20 30.7 2023-12-13 34.6
2024-02-19 30.5 2023-12-12 34.8
2024-02-16 31.2 2023-12-11 35.0
2024-02-15 31.2 2023-12-08 35.0
2024-02-14 29.5 2023-12-07 34.5
2024-02-13 30.3 2023-12-06 34.6
2024-02-12 30.3 2023-12-05 34.5
2024-02-09 30.3 2023-12-04 34.8
2024-02-08 29.8 2023-12-01 34.6
2024-02-07 29.5 2023-11-30 34.5
2024-02-06 29.5 2023-11-29 34.3
2024-02-05 29.3 2023-11-28 34.1
2024-02-02 30.0 2023-11-27 34.5
2024-02-01 30.7 2023-11-24 34.5
2024-01-31 30.7 2023-11-23 34.3
2024-01-30 31.0 2023-11-22 34.5
2024-01-29 31.0 2023-11-21 34.3
2024-01-26 31.0 2023-11-20 34.6

National Research Corp (STU:NR1A) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

National Research Corp logo
National Research Corp
NAICS : 923120 SIC : 7372
ISIN : US6373722023

Share Class Description:

STU:NR1A: Class A
Description
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.